Assessing vaccine safety communication with healthcare providers in a large urban county
Authors:
- 29 September 2011
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 21 (3) , 269-275
Abstract
Purpose: Vaccination is the primary public health tool for influenza control. Rapid assessment of the safety of any widely disseminated pandemic influenza vaccine is a public health priority. This study identifies practices, strengths, and weaknesses of vaccine‐associated adverse event (AE) reporting to inform public health systems improvement.Methods: A survey was developed with local and state health agencies' input. After pre‐testing, the survey was distributed online and via mail to a random sample of King County, WA, healthcare professionals, composed of 60 commercial vaccinator employees and school health nurses, 500 physicians, and 300 pharmacists.Results: The response rate was 36%. Results indicate that if an AE was suspected, 17% of respondents would not know how to report it, with 61% of respondents citing unclear definitions of a reportable AE as a barrier and 18% of respondents unaware of whose responsibility it is to report an AE.Conclusion: Healthcare professionals who provide immunizations need additional information on their role in vaccine safety and AE reporting. Strengthening both passive and active reporting systems can enhance surveillance efforts during real‐time events, such as mass immunization during a pandemic and other large‐scale emergency countermeasure distribution programs. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 27 references indexed in Scilit:
- Active Influenza Vaccine Safety SurveillanceMedical Care, 2009
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesThe Lancet, 2009
- Reporting of Adverse Drug Reactions by General PractitionersDrug Safety, 2009
- Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plansPharmacoepidemiology and Drug Safety, 2008
- Active Surveillance of Vaccine SafetyEpidemiology, 2005
- Guillain-Barré Syndrome Following Influenza VaccinationJAMA, 2004
- Understanding vaccine safety information from the Vaccine Adverse Event Reporting SystemThe Pediatric Infectious Disease Journal, 2004
- Monitoring the Safety of VaccinesDrug Safety, 2002
- InfluenzaThe Lancet, 1999
- Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United StatesPediatrics, 1997